Centogene to present at the h.c. wainwright global investment conference

Cambridge, mass. and rostock, germany and berlin, may 19, 2022 (globe newswire) -- centogene n.v. (nasdaq: cntg), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced that company management will present in the virtual track at the h.c. wainwright global investment conference being held may 23–26, 2022, and invites investors to participate via virtual one-on-one meetings.
CNTG Ratings Summary
CNTG Quant Ranking